Cargando…
Dose relationship between oral glucocorticoids and tumor necrosis factor inhibitors and the risk of hospitalized infectious events among patients with rheumatoid arthritis
The objective of this study was to evaluate the impact of oral glucocorticoid (GC) dose on rates of hospitalized infectious events (HIEs) among RA patients newly exposed to tumor necrosis factor inhibitor (TNFi) therapy. This retrospective cohort study used data from the MarketScan claims database....
Autores principales: | Schenfeld, Jennifer, Iles, Jan, Trivedi, Mona, Accortt, Neil A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486791/ https://www.ncbi.nlm.nih.gov/pubmed/28255642 http://dx.doi.org/10.1007/s00296-017-3679-4 |
Ejemplares similares
-
Changes in Healthcare Utilization After Etanercept Initiation in Patients with Rheumatoid Arthritis: A Retrospective Claims Analysis
por: Accortt, Neil A., et al.
Publicado: (2017) -
Small intestinal injury in NSAID users suffering from rheumatoid arthritis or osteoarthritis
por: Tachecí, Ilja, et al.
Publicado: (2016) -
Impact of Sustained Remission on the Risk of Serious Infection in Patients With Rheumatoid Arthritis
por: Accortt, Neil A., et al.
Publicado: (2018) -
Long-term use of biologic agents does not increase the risk of serious infections in elderly patients with rheumatoid arthritis
por: Kawashima, Hirotoshi, et al.
Publicado: (2016) -
Oral adverse events following COVID-19 and influenza vaccination in Australia
por: Riad, Abanoub, et al.
Publicado: (2023)